Cargando…

TooManyPeaks identifies drug-resistant-specific regulatory elements from single-cell leukemic epigenomes

Emerging single-cell epigenomic assays are used to investigate the heterogeneity of chromatin activity and its function. However, identifying cells with distinct regulatory elements and clearly visualizing their relationships remains challenging. To this end, we introduce TooManyPeaks to address the...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwartz, Gregory W., Zhou, Yeqiao, Petrovic, Jelena, Pear, Warren S., Faryabi, Robert B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409102/
https://www.ncbi.nlm.nih.gov/pubmed/34433064
http://dx.doi.org/10.1016/j.celrep.2021.109575
_version_ 1783746930655887360
author Schwartz, Gregory W.
Zhou, Yeqiao
Petrovic, Jelena
Pear, Warren S.
Faryabi, Robert B.
author_facet Schwartz, Gregory W.
Zhou, Yeqiao
Petrovic, Jelena
Pear, Warren S.
Faryabi, Robert B.
author_sort Schwartz, Gregory W.
collection PubMed
description Emerging single-cell epigenomic assays are used to investigate the heterogeneity of chromatin activity and its function. However, identifying cells with distinct regulatory elements and clearly visualizing their relationships remains challenging. To this end, we introduce TooManyPeaks to address the need for the simultaneous study of chromatin state heterogeneity in both rare and abundant subpopulations. Our analyses of existing data from three widely used single-cell assays for transposase-accessible chromatin using sequencing (scATAC-seq) show the superior performance of TooManyPeaks in delineating and visualizing pure clusters of rare and abundant subpopulations. Furthermore, the application of TooManyPeaks to new scATAC-seq data from drug-naive and drug-resistant leukemic T cells clearly visualizes relationships among these cells and stratifies a rare “resistant-like” drug-naive sub-clone with distinct cis-regulatory elements.
format Online
Article
Text
id pubmed-8409102
institution National Center for Biotechnology Information
language English
publishDate 2021
record_format MEDLINE/PubMed
spelling pubmed-84091022021-09-01 TooManyPeaks identifies drug-resistant-specific regulatory elements from single-cell leukemic epigenomes Schwartz, Gregory W. Zhou, Yeqiao Petrovic, Jelena Pear, Warren S. Faryabi, Robert B. Cell Rep Article Emerging single-cell epigenomic assays are used to investigate the heterogeneity of chromatin activity and its function. However, identifying cells with distinct regulatory elements and clearly visualizing their relationships remains challenging. To this end, we introduce TooManyPeaks to address the need for the simultaneous study of chromatin state heterogeneity in both rare and abundant subpopulations. Our analyses of existing data from three widely used single-cell assays for transposase-accessible chromatin using sequencing (scATAC-seq) show the superior performance of TooManyPeaks in delineating and visualizing pure clusters of rare and abundant subpopulations. Furthermore, the application of TooManyPeaks to new scATAC-seq data from drug-naive and drug-resistant leukemic T cells clearly visualizes relationships among these cells and stratifies a rare “resistant-like” drug-naive sub-clone with distinct cis-regulatory elements. 2021-08-24 /pmc/articles/PMC8409102/ /pubmed/34433064 http://dx.doi.org/10.1016/j.celrep.2021.109575 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ).
spellingShingle Article
Schwartz, Gregory W.
Zhou, Yeqiao
Petrovic, Jelena
Pear, Warren S.
Faryabi, Robert B.
TooManyPeaks identifies drug-resistant-specific regulatory elements from single-cell leukemic epigenomes
title TooManyPeaks identifies drug-resistant-specific regulatory elements from single-cell leukemic epigenomes
title_full TooManyPeaks identifies drug-resistant-specific regulatory elements from single-cell leukemic epigenomes
title_fullStr TooManyPeaks identifies drug-resistant-specific regulatory elements from single-cell leukemic epigenomes
title_full_unstemmed TooManyPeaks identifies drug-resistant-specific regulatory elements from single-cell leukemic epigenomes
title_short TooManyPeaks identifies drug-resistant-specific regulatory elements from single-cell leukemic epigenomes
title_sort toomanypeaks identifies drug-resistant-specific regulatory elements from single-cell leukemic epigenomes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409102/
https://www.ncbi.nlm.nih.gov/pubmed/34433064
http://dx.doi.org/10.1016/j.celrep.2021.109575
work_keys_str_mv AT schwartzgregoryw toomanypeaksidentifiesdrugresistantspecificregulatoryelementsfromsinglecellleukemicepigenomes
AT zhouyeqiao toomanypeaksidentifiesdrugresistantspecificregulatoryelementsfromsinglecellleukemicepigenomes
AT petrovicjelena toomanypeaksidentifiesdrugresistantspecificregulatoryelementsfromsinglecellleukemicepigenomes
AT pearwarrens toomanypeaksidentifiesdrugresistantspecificregulatoryelementsfromsinglecellleukemicepigenomes
AT faryabirobertb toomanypeaksidentifiesdrugresistantspecificregulatoryelementsfromsinglecellleukemicepigenomes